Sensei Biotherapeutics presented clinical data at the ESMO Congress on July 30, 2025.
1 report, 1 independent
Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Sensei Biotherapeutics presented clinical data at the ESMO Congress on July 30, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
European Society for Medical Oncology
Professional organisation
Related events
- Researchers presented Phase 3 clinical data at the European Society for Medical Oncology (ESMO) Congress on September 21, 2026.
- Eli Lilly and Company presented oncology data at the European Society for Medical Oncology (ESMO) Congress.
- AbbVie presented clinical data at the European Society for Medical Oncology (ESMO) Congress held in Madrid.
- Faron Pharmaceuticals presented clinical data at the ESMO Congress on October 19, 2026.
- Study results were presented by Tempus and Pfizer at the ESMO Congress, focusing on ongoing collaboration regarding diagnostic barriers.
Coverage
Newest first; wire copies grouped- GlobeNewswireSensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025 BOSTON, July 30, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc.